Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Carl Zeiss Meditec AG's pretax income for the
six
months ended in Mar. 2026 was €21 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2026 was €128 Mil.
Carl Zeiss Meditec AG's pretax margin was 2.14%.
During the past 13 years, Carl Zeiss Meditec AG's highest Pretax Margin was 21.20%. The lowest was 7.64%. And the median was 14.87%.
During the past 13 years, Carl Zeiss Meditec AG's highest Pretax Margin was 21.20%. The lowest was 7.64%. And the median was 14.87%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG Pre-Tax Income Related Terms
Carl Zeiss Meditec AG Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AFXD vs ISRG, BDX, RMD: Pre-Tax Income Comparison
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG Pre-Tax Income vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €128 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (CHIX:AFXD) has a Pre-Tax Income of €128 Mil as of Mar. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's Pre-Tax Income too high?
Carl Zeiss Meditec AG's current Pre-Tax Income is €128 Mil. Overall, Carl Zeiss Meditec AG has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Pre-Tax Income compare to ISRG and BDX?
Carl Zeiss Meditec AG's Pre-Tax Income of €128 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Medical Devices & Instruments company?
A good Pre-Tax Income depends on the Medical Devices & Instruments industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current Pre-Tax Income is €128 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (CHIX:AFXD) is currently considered Significantly Undervalued. The stock's GF Value™ is €130.01, compared to a current price of €29.66 — trading 77.2% below its estimated fair value. The current Pre-Tax Income is €128 Mil. Carl Zeiss Meditec AG's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Carl Zeiss Meditec AG (CHIX:AFXD), the current Pre-Tax Income is €128 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (CHIX:AFXD) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of €29.66 is trading 77.2% below its estimated GF Value™ of €130.01.
GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.
Key valuation signals for CHIX:AFXD:
Pre-Tax Income: €128 Mil
GF Value™: €130.01 vs. price of €29.66 (77.2% below fair value)
No single metric tells the full story. See the CHIX:AFXD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
65GF Score
Get the complete analysis for CHIX:AFXD
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AFXD has been successfully added to your 
